Visual Abstract
Keywords: GABRD, GABRG2, entrainment, tonic inhibition, phasic inhibition, circadian, GABA
Abstract
Recent molecular studies suggest that the expression levels of δ and γ2 GABAA receptor (GABAAR) subunits regulate the balance between synaptic and extrasynaptic GABA neurotransmission in multiple brain regions. We investigated the expression of GABAAδ and GABAAγ2 and the functional significance of a change in balance between these subunits in a robust local GABA network contained within the suprachiasmatic nucleus of the hypothalamus (SCN). Muscimol, which can activate both synaptic and extrasynaptic GABAARs, injected into the SCN during the day phase advanced the circadian pacemaker, whereas injection of the extrasynaptic GABAA superagonist 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) had no effect on circadian phase. In contrast, injection of either THIP or muscimol during the night was sufficient to block the phase shifting effects of light. Gene expression analysis of the whole SCN revealed different temporal patterns in GABAAδ and GABAAγ2 mRNA expression. When examined across all subregions of the SCN, quantitative immunohistochemical analysis found no significant variations in GABAAδ protein immunoreactivity (IR) but did find significant variations in GABAAγ2 protein-IR in hamsters housed in either LD cycles or in constant darkness. Remarkably, significant interactions in the ratio of GABAAδ:GABAAγ2 subunits between lighting condition and circadian phase occurred only within one highly discrete anatomical area of the SCN; a region that functions as the input for lighting information from the retina. Taken together, these data support the hypothesis that the balance between synaptic and extrasynaptic GABAARs determines the functional response to GABA, and that this balance is differentially regulated in a region-specific manner.
Significance Statement
GABA neurotransmission is mediated primarily by GABAA receptors (GABAARs). These receptors are composed of different combinations of five subunits that determine their pharmacological properties and subcellular location. Differences in the expression of GABAARs that contain the γ2 subunit versus those that contain the δ subunit may regulate the balance between synaptic and extrasynaptic GABA neurotransmission. We report here that expression of the γ2 and the δ subunits are differentially regulated within the circadian pacemaker in the suprachiasmatic nucleus (SCN) and provide evidence that the balance between synaptic and extrasynaptic GABAARs determine the functional response to GABA and that this balance is regulated in a site-specific manner within the SCN.
Introduction
GABA, the primary inhibitory neurotransmitter in the brain, plays a key role in regulating the firing patterns of individual neurons and entire neural networks (Fritschy and Panzanelli, 2014). GABAA receptors (GABAARs) are pentameric chloride channels comprised of three different proteins from 19 available subunits and are generally composed of two α, two β, and one γ, δ, or ε subunit (Olsen and Sieghart, 2009; Sigel and Steinmann, 2012; Fritschy and Panzanelli, 2014). Subunit composition determines their anatomic location and physiologic properties (Fritschy and Panzanelli, 2014).
α4, α5, α6, and δ subunits are found at peri- and extrasynaptic locations, whereas α1 and γ2 are found within the synapse (Farrant and Nusser, 2005). γ2 and δ subunits are mutually exclusive in receptor complexes (Araujo et al., 1998) and have different properties. δ GABAARs display tonic chloride conductance, do not readily desensitize, and are referred to as GABAA-TONIC receptors (Stell and Mody, 2002; Albers et al., 2017). γ2 GABAARs form perisynaptic clusters that then move into the synapse (Essrich et al., 1998; Danglot et al., 2003), where they modulate fast (phasic) conductance, rapidly desensitize following activation, have 50-fold lower GABA affinity, and are referred to as GABAA-PHASIC receptors (Stell and Mody, 2002; Albers et al., 2017). Although much is known about the diversity of GABAARs, little is known about their transcriptional regulation (Fritschy and Panzanelli, 2014) and even less about their specific roles in coregulating GABA networks.
The SCN in the anterior hypothalamus is the central circadian pacemaker that entrains an organism’s physiology and behavior to environmental light-dark (LD) cycles (Stephan and Zucker, 1972). The SCN provides the opportunity to study the network properties of GABA, because it contains a robust local GABA network with distinct inputs (e.g., light) and easily measured outputs (e.g., phase shift in circadian rhythms). Given that all or nearly all neurons within the SCN produce GABA as a neurotransmitter, it is likely that GABA has a fundamental role in circadian timekeeping (van den Pol, 1986; Moore and Speh, 1993; Castel and Morris, 2000; Albers et al., 2017). Indeed, GABA plays a major role in the ability of the circadian pacemaker to be reset by environmental stimuli. Muscimol, an agonist which activates GABAARs that contain either the γ2 or the δ subunit, injected into the SCN phase advances the circadian pacemaker during subjective day (Smith et al., 1989; Huhman et al., 1995; Mintz et al., 2002; Ehlen et al., 2006; Biello, 2009), mimicking the effects of nonphotic stimuli (e.g., locomotor activity; Mrosovsky et al., 1992; Mrosovsky, 1996). Diazepam, a benzodiazepine that acts at γ2 containing receptors similarly phase advances the clock during the subjective day (McElroy et al., 2009).
GABAARs are also critical in the phase resetting effects of light. Acute administration of muscimol into the SCN blocks the ability of light to induce phase delays in the early subjective night and phase advances during the late subjective night (Gillespie et al., 1996, 1997, 1999; Novak and Albers, 2004). Acute administration of the nonselective GABAA antagonist bicuculline enhances light-induced phase delays during the early subjective night (Gillespie et al., 1996). More recently, the sustained activation of GABAARs has been found to be both necessary and sufficient to mediate the phase delaying effects of light during the early subjective night (Hummer et al., 2015). Taken together, it is clear that GABAARs play a fundamental role in determining how both light and nonphotic signals influence the phase of the pacemaker found within the SCN.
Despite the importance of GABAARs in regulating the phase of the circadian pacemaker, the role of GABAARs composed of different subunits is not well understood. Based on several studies, there is a consensus that α1, α2, β1, β2, and γ2 subunit mRNA or proteins are expressed in the SCN (Gao et al., 1995; O'Hara et al., 1995; Naum et al., 2001). To our knowledge, only one study has investigated GABAAδ in the SCN and reported it undetectable by Western blotting (O'Hara et al., 1995). Pharmacological evidence, however, indicates the presence of and a separate role in entrainment for both δ and γ2 GABAARs in the SCN (Ehlen and Paul, 2009; McElroy et al., 2009). The aim of this study was to investigate how the expression of GABAAδ and γ2 subunits varies within the SCN across circadian time (CT) to test the hypothesis that rhythms in GABAA-TONIC (δ) and GABAA-PHASIC (γ2) receptors and/or their ratio mediate the phase-dependent effects of GABA on the circadian pacemaker.
Materials and Methods
Animals and housing
Adult male Syrian hamsters (Mesocricetus auratus, 120–150 g) were purchased from Charles River Laboratories. On arrival, hamsters were singly housed in polycarbonate cages (23 × 43 × 20 cm) with corncob bedding, given ad libitum access to food (#5001; Lab Diet) and water, and maintained in 14:10 light:dark (LD) cycle for 7–10 d before any manipulation. The Department of Animal Resources at Georgia State University provided all animal husbandry. All procedures were approved by the Georgia State University Institutional Animal Care and Use Committee and were in compliance with guidelines established by the National Institutes of Health [Institute for Laboratory Animal Research (U.S.), 2011] and established by the Society for Neuroscience.
Experiment 1: Effects of GABAAR subtype-specific agonists on phase resetting
Under isoflurane anesthesia, hamsters were stereotaxically implanted with a 26-ga guide cannula (PlasticsOne) aimed at the SCN region (AP +0.7 mm; ML +1.7 mm; 10° angle toward midline). Cannulae were anchored to the skull with bone screws and cranioplastic cement. Hamsters recovered a minimum of 7 d in LD, and were then given access to a running wheel (33 cm diameter; Techniplast) and placed in constant darkness (0:24 light:dark; DD). Running wheel activity rhythms were recorded remotely using VitalView software (Starr Life Sciences) and phase shifts in activity onsets were quantified using the linear regression method (Pittendrigh and Daan, 1976) and ClockLab software (Actimetrics). By convention, for nocturnal animals CT12 was defined as the time of activity onset. After a minimum of 10 d in DD, microinjections (200 nl, administered over a 20 s period) were given under dim red light with a 1.0-μl Hamilton syringe connected to a 33-ga needle that projected to a final depth of 7.8 mm below bregma. The needle remained in place for 20 s after the injection. The GABAAδ superagonist 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) and the nonselective GABAA agonist muscimol, purchased from Sigma, were dissolved in sterile 0.9% saline at concentrations of 110 and 11 mM, respectively (Ehlen and Paul, 2009; Hummer et al., 2015), immediately before injections. Although THIP is a superagonist at extrasynaptic (δ) receptors, it is only a partial agonist at synaptic (γ2) receptors at high concentrations (Hansen et al., 2001). Furthermore, THIP has very low affinity for native intrasynaptic γ2 receptors (Drasbek and Jensen, 2006), thus it is likely only affecting extrasynaptic GABAAδ receptors in vivo. For injections at CT6, hamsters were returned to their home cage in DD immediately after the injection. Injections at CT13.5 or CT19 were immediately followed by a 15-min 150 lux light pulse after which hamsters were returned to their home cages in DD. Hamsters with stable rhythms received an additional microinjection 10–14 d following the first treatment (to allow for stable reestablishment of the free-running rhythm) and were returned to running wheels in DD for another 10–14 d. No hamster received more than two injections. At the conclusion of testing, hamsters were killed by sodium pentobarbital overdose and then injected with ink to verify cannula placement. After histologic examination, hamsters with injection sites found to surround (within 500 μm), but not damage the SCN, were included in the analyses. It has been previously shown that drugs injected 500 μm or further from the SCN border do not phase shift the circadian pacemaker (Hummer et al., 2015) and that injections in a volume of 200 nl (the volume used in the present study) spread slightly less than a mm from the tip of the injection needle (Albers et al., 1990; Caldwell and Albers, 2003). The hamster SCN is ∼0.6 mm in the rostral-caudal plane, ∼0.3 mm in the mediolateral plane, and ∼0.6 mm in the dorso-ventral plane (Lydic et al., 1982). Because the hamster SCN lies ventral and not lateral to the third ventricle, and the SCN actually merge bilaterally midway along the dorsoventral axis, there is little barrier to the spread of drugs bilaterally. Indeed, it has been shown that injections using a volume of 200 nl diffuse bilaterally throughout the SCN (Gillespie et al., 1999; Paul et al., 2005). Taken together, these data suggest that injections within 500 μm of the SCN should diffuse throughout the bilateral SCN and for a short distance outside the borders of the nucleus.
Experiment 2: GABAAR subunit gene expression in the SCN
After habituation to the animal facility, hamsters either remained in LD or were placed in DD and given access to running wheels as described in experiment 1 above. After 10 additional days in either LD or DD, hamsters were given a lethal overdose of sodium pentobarbital, decapitated, and brains were rapidly removed and placed in 2.5 ml of RNAlater (Ambion) then held at 4°C for one to two weeks before RNA extraction. Brains were collected at zeitgeber time (ZT)6, ZT13, and ZT19 from hamsters in LD, and at CT6, CT13, and CT19 from hamsters in DD. By convention for nocturnal animals ZT12 is the onset of activity, thus in the 14:10 LD cycle lights on occurred at ZT22 and lights off at ZT12. For ZT13, ZT19, and all DD time points, brains were collected under dim red light (<5 lux). After RNA stabilization in RNAlater, brains were then placed in a matrix and a 1.0 mm thick slice containing the SCN was collected onto a glass slide. SCN were then collected into 200 μl of Trizol (Ambion) using a 1.0-mm tissue punch. Individual SCN were homogenized in 1.0 ml Trizol using a sterile pestle and RNA was extracted following manufacturer’s protocol. RNA was washed twice with chloroform and precipitated with 100% isopropanol. The pellet was then washed twice with 75% ethanol, resuspended in 20 μl of water, and RNA concentration was determined using a NanoDrop 2000. Following extraction, 150 ng of total RNA was then reverse transcribed into cDNA using M-MLV (Promega) following the manufacturer’s protocol. Relative gene expression was quantified using an ABI 7500 FAST Real-Time system using Taqman Universal PCR master mix and the following universal two-step RT-PCR cycling conditions: 50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The following primer/probe sets from Applied Biosystems were used: GABAAδ (ABI Mm01266203_g1), GABAAγ2 (ABI Rn00788325_m1), and 18s (4319413E). Relative gene expression for each sample run in duplicate was calculated by comparing to a relative standard curve and then standardized to 18S rRNA expression. Relative cDNA standards were generated using pooled hippocampal RNA extracts, which included tissue from animals at each CT point.
Experiment 3: GABAAR subunit protein expression in the SCN
Hamsters were housed as described in experiment 2 above. At the same circadian and zeitgeber time points as described in experiment 2, hamsters were given a lethal overdose of sodium pentobarbital, followed by a transcardial perfusion with 100 ml of ice cold 0.1 M PBS, pH 7.4, then followed by 100 ml of freshly made ice cold 4% paraformaldehyde in 0.1 M PBS. Brains were removed and postfixed in 4% paraformaldehyde 0.1 M PBS at 4°C. After 12–16 h of postfixation, brains were placed in 0.1 M PB + 30% sucrose at 4°C. Once brains had sunk in the sucrose solution, they were then flash frozen in 2-methylbutane on dry ice, and held at −80°C until sectioning. Brains were sectioned at 40 μm on a cryostat, and three sets of serial coronal sections containing the SCN were collected into cryoprotectant and held at −20°C for immunohistochemical staining. A representative series of sections from each brain was then processed for either GABAAδ (Millipore catalog AB9752, RRID:AB_672966) or GABAAγ2 (Abcam catalog ab16213, RRID:AB_302324). Briefly, free floating tissue sections were rinsed three times in 0.1 M PBS + 0.1% Triton X-100 (PBST), blocked in 10% normal goat serum (NGS) in PBST for 30 min, and incubated in primary antibody (1:250 in PBST + 10% NGS) overnight at 4°C. Sections were then rinsed in PBST and incubated in secondary antibody (Jackson ImmunoResearch 111-065-003; 1:500 in PBS + 5% NGS) for 2 h at room temperature. After secondary incubation, tissue was rinsed in PBS, complexed with ABC (Avidin/Biotinylated enzyme Complex, Vector PK-6100), and developed with nickel 3,3’-diaminobenzidine (Ni-DAB; Vector SK-4100) according to the manufacturer’s protocols. Sections were then mounted onto chrome-gel subbed slides, dried, dehydrated in a graded ethanol series, cleared with xylenes, and coverslipped with Permount (Fisher). Immunohiostochemistry was yoked so that all tissue sections for each protein of interest were processed simultaneously allowing for direct comparisons of relative protein levels among groups.
Digital monochrome images were captured at 100× using a Zeiss Axioplan2 microscope fitted with a ProgRes SpeedXT core5 camera (JENOPTOK). All images used for protein quantification were taken in a single session without altering microscope or camera settings. For each representative series of brain sections, four images were captured representing the rostral, central anterior, central posterior, and caudal SCN as previously described in hamsters (LeSauter et al., 2002; Hamada et al., 2004). These regions correspond to those found in figures 23–25 of the golden hamster brain atlas (Morin and Wood, 2001). Using ImageJ, a region of interest (ROI) was defined that included the entire unilateral SCN. This ROI was then used to measure grayscale values of the SCN in each image. The grayscale value corresponds to the optical density of the DAB staining and thus is a measure of relative protein expression. Grayscale values were then inverted (255, measured value), so that higher numbers were indicative of relatively more protein-IR. Given that there is ongoing controversy about the functional neuroanatomical subdivisions of the SCN (reviewed in Moore et al., 2002; Lee et al., 2003; Morin and Allen, 2006; Morin, 2007; Evans, 2016; Evans and Gorman, 2016; Albers et al., 2017), and that GABAA subunit distribution has been reported to vary across the rostro-caudal and dorso-ventral extent of the SCN (Gao et al., 1995; Belenky et al., 2003), we measured and analyzed protein expression in several different ways. First we analyzed the whole SCN by averaging the grayscale values of each ROI across the rostral-caudal extent, resulting in a single value for each whole SCN. Next, for a dorsal versus ventral anatomic division of the SCN, the initial ROI was further divided in half on the dorsal-ventral axis, and grayscale values were measured for each image and then averaged across the rostro-caudal extent of each SCN as described above, resulting in one dorsal and one ventral grayscale value. Finally, grayscale values were collected for each individual sub-ROI, resulting in eight grayscale values for each SCN (dorsal and ventral × four rostro-caudal divisions). All measurements were made by an observer blind to the experimental condition of the hamster.
Based on studies using genetic techniques in mice, GABAA γ2 and δ appear to reciprocally regulate each other’s expression independent of receptor activity (Korpi et al., 2002; Wu et al., 2013). Thus, we also compared the relative protein-IR levels for the two GABAAR subtypes by comparing the relationship of their relative ratios (δ-IR:γ2-IR) across time points and lighting conditions. Although this ratio does not represent a direct measure of the absolute amounts of protein within the SCN, it does represent the relative change in the amounts of these proteins in relation to each other.
Statistics
All statistical analyses were performed using SPSS 22.0 (IBM). Pharmacological data (experiment 1) were analyzed using one-way ANOVA (analysis of variance) with phase shift as the dependent variable and drug treatment as the independent variable. Significant ANOVAs were followed up with a Fisher’s LSD post hoc test. For experiment 2, gene expression data were also analyzed by one-way ANOVA with relative expression or expression ratio as the dependent variable and zeitgeber time or circadian time as independent variables. Significant ANOVAs were followed up with a Fisher’s LSD post hoc test. Gene expression data were also analyzed by independent samples t test with circadian phase as the independent variable. Protein-IR data were first analyzed using one-way ANOVA and independent samples t test as described above. To ascertain the anatomic location in the SCN of interactions between light regimen and circadian phase, protein-IR data were then analyzed by SCN anatomic subdivision using 2 × 2 MANOVA (multivariate analysis of variance) with grayscale value or expression ratio as the dependent variable and circadian phase and lighting condition as independent variables. To ascertain the effects of environmental lighting condition on GABAA protein-IR, data were analyzed using an independent samples t test with lighting regimen (LD vs DD) as the independent variable. Finally, to ascertain the differences in GABAA protein-IR between the dorsal and ventral SCN, a different independent samples t test was performed using these two factors as the independent variables. Differences were considered statistically significant at p ≤ 0.05. The numbers of animals used in each experiment are listed in Table 7.
Table 7.
Experiment | Group | N |
---|---|---|
1 | CT6 SALINE-NP | 7 |
CT6 THIP-NP | 8 | |
CT6 MUSCIMOL-NP | 9 | |
CT13.5 SALINE-LP | 3 | |
CT13.5 THIP-LP | 6 | |
CT13.5 MUSCIMOL-LP | 5 | |
CT13.5 THIP-NP | 3 | |
CT13.5 MUSCIMOL-NP | 4 | |
CT19 SALINE-LP | 6 | |
CT19 THIP-LP | 4 | |
CT19 MUSCIMOL-LP | 5 | |
CT19 THIP-NP | 3 | |
CT19 MUSCIMOL-NP | 4 | |
2 | CT6 | 5 |
CT13.5 | 5 | |
CT19 | 6 | |
ZT6 | 6 | |
ZT13.5 | 6 | |
ZT19 | 5 | |
3 | CT6 | 5 |
CT13.5 | 5 | |
CT19 | 5 | |
ZT6 | 4 | |
ZT13.5 | 4 | |
ZT19 | 4 |
Results
Experiment 1: Phase shifting effects of GABAA agonists
During the subjective day (CT6), the GABAAγ2/GABAAδ agonist muscimol induced a phase advance in circadian wheel running activity, whereas neither saline or the GABAAδ superagonist THIP had any effect on circadian phase (F(2,21) = 8.544, p ≤ 0.05; Fig. 1A). During the subjective night, both THIP and muscimol blocked the phase delaying (CT13.5, F(4,16) = 16.438, p ≤ 0.05; Fig. 1B) and phase advancing (CT19, F(4,17) = 5.455, p ≤ 0.05; Fig. 1C) effects of a light pulse when compared with saline (Fig. 1). THIP was more effective than muscimol in blocking a light-induced phase delay during the early subjective night (CT13.5, p ≤ 0.05; Fig. 1B). However, in the absence of a light pulse at CT13.5, animals treated with THIP showed a small phase delay compared with those treated with muscimol (Fig. 1B; Table 1). Neither muscimol nor THIP had an effect on phase in the absence of a light pulse during the late subjective night (p > 0.05; Fig. 1C).
Table 1.
One-way ANOVA | |||
---|---|---|---|
CT | F statistic | p value | |
CT6 | (2,21) = 8.544 | *0.002 | |
CT13.5 | (4,16) = 16.438 | *0.000 | |
CT19 | (4,17) = 5.455 | *0.005 | |
LSD post hoc | |||
CT | Treatment vs | Treatment | p value |
CT6 | SALINE-NP | MUSCIMOL-NP | *0.001 |
THIP-NP | 0.488 | ||
MUSCIMOL-NP | SALINE-NP | *0.001 | |
THIP-NP | *0.004 | ||
THIP-NP | SALINE-NP | 0.488 | |
MUSCIMOL-NP | *0.004 | ||
CT13.5 | SALINE-LP | MUSCIMOL-LP | *0.000 |
THIP-LP | *0.000 | ||
MUSCIMOL-NP | *0.000 | ||
THIP-NP | *0.000 | ||
MUSCIMOL-LP | SALINE-LP | *0.000 | |
THIP-LP | *0.019 | ||
MUSCIMOL-NP | *0.015 | ||
THIP-NP | 0.913 | ||
THIP-LP | SALINE-LP | *0.000 | |
MUSCIMOL-LP | *0.019 | ||
MUSCIMOL-NP | 0.696 | ||
THIP-NP | 0.051 | ||
MUSCIMOL-NP | SALINE-LP | *0.000 | |
MUSCIMOL-LP | *0.015 | ||
THIP-LP | 0.696 | ||
THIP-NP | *0.036 | ||
THIP-NP | SALINE-LP | *0.000 | |
MUSCIMOL-LP | 0.913 | ||
THIP-LP | 0.051 | ||
MUSCIMOL-NP | *0.036 | ||
CT19 | SALINE-LP | MUSCIMOL-LP | *0.003 |
THIP-LP | *0.001 | ||
MUSCIMOL-NP | *0.007 | ||
THIP-NP | *0.006 | ||
MUSCIMOL-LP | SALINE-LP | *0.003 | |
THIP-LP | 0.541 | ||
MUSCIMOL-NP | 0.863 | ||
THIP-NP | 0.879 | ||
THIP-LP | SALINE-LP | *0.001 | |
MUSCIMOL-LP | 0.541 | ||
MUSCIMOL-NP | 0.459 | ||
THIP-NP | 0.694 | ||
MUSCIMOL-NP | SALINE-LP | *0.007 | |
MUSCIMOL-LP | 0.863 | ||
THIP-LP | 0.459 | ||
THIP-NP | 0.766 | ||
THIP-NP | SALINE-LP | *0.006 | |
MUSCIMOL-LP | 0.879 | ||
THIP-LP | 0.694 | ||
MUSCIMOL-NP | 0.766 |
p < 0.05.
Experiment 2: GABAAR subunit gene expression in the SCN
When relative mRNA expression was analyzed by one-way ANOVA with time of day as the independent variable, variation in mRNA levels for both subunits did not reach statistical significance in either LD or DD (p > 0.05; Fig. 2; Table 2). However, when analyzed using an independent samples t test with circadian phase (light vs dark phase in LD; active vs inactive phase in DD) as the independent variable, differences in expression were apparent. The GABAAδ receptor subunit mRNA varied by circadian phase (i.e., ZT6 vs ZT13 and ZT19) in SCN dissections from hamsters housed under LD conditions (t(15) = 2.498, p ≤ 0.05), with the highest expression during the light (inactive) phase (Fig. 2A). In contrast, the mRNA encoding the GABAAγ2 receptor subunit did not vary between the dark (active) and light (inactive) phases in LD (t(15) = −0.979, p > 0.05; Fig. 2B). The ratio of the GABAAδ receptor subunit mRNA to the GABAAγ2 receptor subunit did not vary by circadian phase in LD (t(15) = 1.181, p > 0.05; Fig. 2C). In hamsters housed in DD, the ratio of GABAAδ receptor subunit mRNA to GABAAγ2 receptor mRNA varied by circadian phase (i.e., CT6 vs CT13 and CT19) after 10 d in DD (t(14) = 2. 317, p ≤ 0.05), with the highest ratio of GABAAδ-to-GABAAγ2 receptor subunit mRNA occurring during the inactive phase (Fig. 2F). There were no differences in GABAAδ receptor subunit mRNA or in GABAAγ2 receptor subunit mRNA in DD due to circadian phase (Fig. 2D,E).
Table 2.
Condition | Type of test | Comparison | Gene | F statistic | t value | p value |
---|---|---|---|---|---|---|
LD | One-way ANOVA | Zeitgeber time | δ | (2,14) = 2.593 | 0.085 | |
One-way ANOVA | (ZT6 vs ZT13 vs ZT19) | γ2 | (2,14) = 0.466 | 0.637 | ||
One-way ANOVA | δ:γ2 | (2,14) = 0.749 | 0.491 | |||
Independent samples t test | Zeitgeber phase | δ | (15) = 2.498 | *0.025 | ||
Independent samples t test | (light vs dark) | γ2 | (15) = −0.979 | 0.343 | ||
Independent samples t test | δ:γ2 | (15) = 1.181 | 0.256 | |||
DD | One-way ANOVA | Circadian time | δ | (2,13) = 2.598 | 0.112 | |
One-way ANOVA | (CT6 vs CT13 vs CT19) | γ2 | (2,13) = 0.946 | 0.413 | ||
One-way ANOVA | δ:γ2 | (2,13) = 2.677 | 0.106 | |||
Independent samples t test | Circadian phase | δ | (14) = 1.036 | 0.318 | ||
Independent samples t test | (inactive vs active) | γ2 | (14) = −1.734 | 0.191 | ||
Independent samples t test | δ:γ2 | (14) = 2.317 | *0.036 |
p < 0.05.
Experiment 3: GABAAR subunit protein-IR in the SCN
Nickel-enhanced DAB immunohistochemistry revealed diffuse IR for both GABAAR subunit proteins throughout the SCN (Fig. 3). This diffuse staining pattern seen in the SCN has been previously reported for multiple GABAAR subunits in a variety of brain regions and neuronal cell types (Terai et al., 1998; Brunig et al., 2002; Crestani et al., 2002; Peng et al., 2004). As mentioned in Materials and Methods above, we measured and analyzed protein-IR in the whole SCN as well as in commonly used subdivisions of the SCN to allow the current results to be integrated with data from functional neuroanatomical subdivisions of the SCN that have been discussed previously (reviewed in Moore et al., 2002; Lee et al., 2003; Morin and Allen, 2006; Morin, 2007; Yan et al., 2007; Evans, 2016; Evans and Gorman, 2016; Albers et al., 2017).
First, to allow direct comparison with the analyses of mRNA expression data in experiment 2, we performed a quantitative analysis of protein-IR of the whole SCN by one-way ANOVA with protein-IR as the dependent variable and zeitgeber time (LD) or circadian time (DD) as independent variables. We also analyzed whole SCN protein-IR using an independent samples t test with circadian phase (light vs dark phase in LD; active vs inactive phase in DD) as the independent variable as in experiment 2 above. Combining the two night time measurements and directly comparing them to the day time represents a functional grouping based on the effects of GABAA-active drugs across the circadian cycle as described above (Smith et al., 1989; Huhman et al., 1995; Gillespie et al., 1996; Gillespie et al., 1997; Gillespie et al., 1999; Mintz et al., 2002; Novak and Albers, 2004; Ehlen et al., 2006; Biello, 2009). The results of both analyses are found in Table 3. The intensity of GABAAδ protein-IR did not vary across time points in hamsters housed in LD (i.e., ZT6 vs ZT13 vs ZT19; Fig. 4A) or in hamsters housed in DD (i.e., CT6 vs CT13 vs CT19; Fig. 4D), nor by phase in hamsters housed in DD (i.e., CT6 vs CT13 and CT19; Fig. 4D). There was, however, a trend for greater GABAAδ protein-IR in the dark (active) phase in hamsters housed in a LD cycle (p = 0.06; Fig. 4A). GABAAγ2 protein-IR varied by time point and by phase in hamsters housed in a LD cycle; protein-IR was at nadir during the day and peak levels occurred at night, with the highest levels in the early night (p ≤ 0.05; Fig. 4B). After free-running in DD for 10 d, a circadian rhythm in GABAAγ2 protein-IR in the SCN was observed, with significantly higher levels occurring during the subjective day (CT6) than during the subjective night (CT13 and CT19, p ≤ 0.05; Fig. 4E). Based on studies using genetic techniques in mice, GABAA γ2 and δ appear to reciprocally regulate each other’s expression and insertion into the cell membrane, independent of receptor activity (Korpi et al., 2002; Wu et al., 2013). Although it was not possible to measure membrane bound subunits, we analyzed the relative ratio of GABAAδ:GABAAγ2 protein-IR as a measure of how the relative amounts of these two proteins vary in relation to each other across the day. The ratio of extrasynaptic:synaptic subunit protein-IR did not vary in the whole SCN in LD or DD (p > 0.05; Fig. 4C,F).
Table 3.
Condition | Type of test | Comparison | Protein | F statistic | t value | p value |
---|---|---|---|---|---|---|
LD | One-way ANOVA | Zeitgeber time | δ | (2,9) = 2.271 | 0.159 | |
One-way ANOVA | (ZT6 vs ZT13 vs ZT19) | γ2 | (2,8) = 8.318 | *0.011 | ||
One-way ANOVA | δ:γ2 | (2,8) = 0.165 | 0.850 | |||
Independent samples t test | Zeitgeber phase | δ | (10) = −2.081 | 0.064 | ||
Independent samples t test | (light vs dark) | γ2 | (9) = −3.444 | *0.007 | ||
Independent samples t test | δ:γ2 | (9) = 0.449 | 0.664 | |||
DD | One-way ANOVA | Circadian time | δ | (2,12) = 0.849 | 0.452 | |
One-way ANOVA | (CT6 vs CT13 vs CT19) | γ2 | (2,12) = 7.754 | *0.011 | ||
One-way ANOVA | δ:γ2 | (2,9) = 0.976 | 0.413 | |||
Independent samples t test | Circadian phase | δ | (10) = −0.085 | 0.933 | ||
Independent samples t test | (inactive vs active) | γ2 | (10) = 4.069 | *0.002 | ||
Independent samples t test | δ:γ2 | (10) = −1.219 | 0.251 |
p < 0.05.
Next, to determine whether there were phase-specific effects of lighting condition on protein-IR, we analyzed the SCN for both proteins of interest using a 2 × 2 MANOVA with grayscale value as the dependent variable and circadian phase (active vs inactive phase; i.e., ZT13, ZT19, CT13, CT19 vs ZT6, CT6) and lighting condition (LD vs DD) as independent variables. Grayscale values from the animal’s active phase represented the average of IR intensities across active time points, e.g., ZT13, ZT19, CT13, CT19, and inactive phase values were averages of IR intensities from ZT6 and CT6. We further analyzed the relationships between GABAAδ and GABAAγ2 subunit protein-IR by dividing the SCN into four regions along the rostral-caudal axis (LeSauter et al., 2002; Hamada et al., 2004), and into dorsal and ventral regions (Moore et al., 2002; Yan et al., 2007) as described in Materials and Methods. Statistics for this analysis are found in Table 4. There was a main effect for lighting condition; differences in both GABAAδ and GABAAγ2 protein-IR were observed between groups housed in LD versus DD in most subregions of the SCN with higher protein-IR in hamsters housed in DD (Fig. 5A–F). In contrast to the effects of lighting condition, there was no main effect for circadian phase; no differences in GABAAδ and GABAAγ2 protein-IR were observed in any of the subregions between the light and dark phase in hamsters housed in LD cycles or between the subjective day and night in hamsters housed in DD (Fig. 5A–F). No interactions were observed between lighting condition and circadian phase in the extrasynaptic GABAAδ protein-IR in any SCN subregion (p > 0.05 for all regions; Fig. 5A–C). However, there was an interaction between lighting condition and phase in GABAAγ2 protein-IR across the whole SCN and in all subregions, with the exception of the rostral SCN (p ≤ 0.05; Fig. 5D–F). Interestingly, an interaction in the ratio of GABAAδ:GABAAγ2 protein-IR between lighting condition and circadian phase was observed only in the central posterior SCN subregion (F(1,1) = 4.72, p ≤ 0.05; Fig. 5G), which is the retinorecipient region in Syrian hamsters (LeSauter et al., 2002; Fig. 3A). Further analysis revealed that this interaction in the ratio of GABAAδ:GABAAγ2 protein-IR between lighting condition and circadian phase was significant in the dorsal central posterior subregion (F(1,1) = 4.81, p ≤ 0.05; Fig. 5H), and nearly reached significance in the ventral central posterior subregion (F(1,1) = 4.13, p = 0.056; Fig. 5I).
Table 4.
SCN region | GABAAδ | GABAAγ2 | GABAAδ:GABAAγ2 | ||||||
---|---|---|---|---|---|---|---|---|---|
MS | F | p | MS | F | p | MS | F | p | |
Whole | |||||||||
Phase | 83.68 | 1.78 | 0.196 | 11.78 | 1.28 | 0.271 | 0.01 | 0.62 | 0.442 |
Light cycle | 323.91 | 6.88 | *0.015 | 126.77 | 13.81 | *0.001 | 0.01 | 0.47 | 0.501 |
Phase × light cycle | 68.48 | 1.45 | 0.240 | 235.19 | 25.62 | *0.000 | 0.02 | 1.56 | 0.226 |
Dorsal | |||||||||
Phase | 73.46 | 1.51 | 0.231 | 7.20 | 0.56 | 0.465 | 0.01 | 0.68 | 0.421 |
Light cycle | 272.70 | 5.61 | *0.027 | 99.44 | 7.67 | *0.012 | 0.01 | 0.43 | 0.518 |
Phase × light cycle | 55.82 | 1.15 | 0.295 | 228.06 | 17.59 | *0.000 | 0.02 | 1.67 | 0.212 |
Ventral | |||||||||
Phase | 106.46 | 2.30 | 0.143 | 23.07 | 3.51 | 0.077 | 0.01 | 0.52 | 0.479 |
Light cycle | 426.95 | 9.23 | *0.006 | 185.34 | 28.19 | *0.000 | 0.01 | 0.51 | 0.483 |
Phase × light cycle | 95.68 | 2.07 | 0.164 | 248.53 | 37.80 | *0.000 | 0.02 | 1.56 | 0.226 |
Rostral | |||||||||
Phase | 122.54 | 2.68 | 0.115 | 5.76 | 0.16 | 0.690 | 0.02 | 1.32 | 0.265 |
Light cycle | 287.92 | 6.30 | *0.020 | 55.32 | 1.58 | 0.224 | 0.02 | 1.31 | 0.267 |
Phase × light cycle | 72.96 | 1.60 | 0.219 | 116.86 | 3.33 | 0.084 | 0.01 | 0.44 | 0.516 |
Central anterior | |||||||||
Phase | 86.75 | 1.68 | 0.208 | 0.00 | 0.00 | 0.997 | 0.01 | 0.61 | 0.446 |
Light cycle | 209.11 | 4.05 | 0.056 | 235.51 | 15.56 | *0.001 | 0.00 | 0.03 | 0.855 |
Phase × light cycle | 41.01 | 0.79 | 0.382 | 160.48 | 10.60 | *0.004 | 0.01 | 0.46 | 0.505 |
Central posterior | |||||||||
Phase | 65.06 | 1.16 | 0.292 | 17.33 | 0.98 | 0.335 | 0.00 | 0.14 | 0.710 |
Light cycle | 351.60 | 6.28 | *0.020 | 260.17 | 14.67 | *0.001 | 0.00 | 0.01 | 0.930 |
Phase × light cycle | 97.42 | 1.74 | 0.200 | 581.64 | 32.80 | *0.000 | 0.06 | 4.72 | *0.043 |
Caudal | |||||||||
Phase | 66.28 | 1.13 | 0.298 | 51.62 | 2.71 | 0.116 | 0.00 | 0.13 | 0.718 |
Light cycle | 475.70 | 8.12 | *0.009 | 37.50 | 1.97 | 0.177 | 0.04 | 2.40 | 0.138 |
Phase × light cycle | 68.66 | 1.17 | 0.290 | 189.02 | 9.92 | *0.005 | 0.02 | 0.86 | 0.366 |
Dorsal rostral | |||||||||
Phase | 112.46 | 2.64 | 0.118 | 7.90 | 0.20 | 0.664 | 0.02 | 1.13 | 0.302 |
Light cycle | 231.78 | 5.45 | *0.029 | 45.00 | 1.11 | 0.305 | 0.02 | 1.13 | 0.300 |
Phase × light cycle | 58.72 | 1.38 | *0.252 | 120.19 | 2.97 | 0.101 | 0.01 | 0.61 | 0.444 |
Dorsal central anterior | |||||||||
Phase | 67.67 | 1.33 | 0.261 | 3.17 | 0.20 | 0.661 | 0.02 | 0.85 | 0.368 |
Light cycle | 161.21 | 3.16 | 0.089 | 233.85 | 14.66 | *0.001 | 0.00 | 0.14 | 0.710 |
Phase × light cycle | 33.37 | 0.65 | 0.427 | 111.93 | 7.02 | *0.016 | 0.01 | 0.29 | 0.595 |
Dorsal central posterior | |||||||||
Phase | 67.79 | 1.14 | 0.297 | 6.02 | 0.28 | 0.605 | 0.01 | 0.45 | 0.512 |
Light cycle | 306.71 | 5.15 | *0.033 | 181.46 | 8.36 | *0.009 | 0.00 | 0.01 | 0.930 |
Phase × light cycle | 82.33 | 1.38 | 0.252 | 554.05 | 25.52 | *0.000 | 0.06 | 4.81 | *0.041 |
Dorsal caudal | |||||||||
Phase | 52.12 | 0.76 | 0.392 | 52.56 | 2.02 | 0.171 | 0.00 | 0.09 | 0.772 |
Light cycle | 425.19 | 6.21 | *0.020 | 19.51 | 0.75 | 0.397 | 0.05 | 2.05 | 0.169 |
Phase × light cycle | 54.35 | 0.79 | 0.382 | 234.85 | 9.04 | *0.007 | 0.03 | 1.28 | 0.273 |
Ventral rostral | |||||||||
Phase | 146.81 | 2.63 | 0.119 | 2.72 | 0.09 | 0.768 | 0.03 | 1.67 | 0.212 |
Light cycle | 402.46 | 7.20 | *0.013 | 76.96 | 2.53 | 0.128 | 0.03 | 1.45 | 0.243 |
Phase × light cycle | 102.11 | 1.83 | 0.190 | 110.90 | 3.64 | 0.072 | 0.00 | 0.17 | 0.687 |
Ventral central anterior | |||||||||
Phase | 132.25 | 2.23 | 0.149 | 10.31 | 0.48 | 0.496 | 0.01 | 0.28 | 0.603 |
Light cycle | 308.83 | 5.20 | *0.032 | 238.55 | 11.16 | *0.003 | 0.00 | 0.02 | 0.885 |
Phase × light cycle | 56.96 | 0.96 | 0.338 | 271.83 | 12.71 | *0.002 | 0.01 | 0.80 | 0.384 |
Ventral central posterior | |||||||||
Phase | 59.39 | 1.06 | 0.313 | 53.12 | 2.53 | 0.128 | 0.00 | 0.01 | 0.908 |
Light cycle | 436.59 | 7.81 | *0.010 | 440.73 | 21.00 | *0.000 | 0.00 | 0.16 | 0.698 |
Phase × light cycle | 130.97 | 2.34 | 0.140 | 633.84 | 30.20 | *0.000 | 0.05 | 4.13 | 0.056 |
Ventral caudal | |||||||||
Phase | 98.98 | 2.22 | 0.150 | 49.92 | 3.90 | 0.063 | 0.00 | 0.34 | 0.569 |
Light cycle | 581.86 | 13.07 | *0.001 | 85.46 | 6.68 | *0.018 | 0.04 | 3.19 | 0.090 |
Phase × light cycle | 100.62 | 2.26 | 0.146 | 118.04 | 9.22 | *0.007 | 0.00 | 0.12 | 0.736 |
Given that we found a significant main effect of environmental lighting condition on protein-IR, we next analyzed our data to determine whether differences existed in protein-IR between LD and DD conditions. Protein-IR values, by SCN subdivision, were averaged across the day for animals in each lighting condition (i.e., LD: average of ZT6, ZT13, and ZT19; DD: average of CT6, 13, and 19), and then analyzed for effects of lighting condition (LD vs DD) by independent samples t test (Table 5). GABAAδ-IR was greater in DD than LD in many subregions of the SCN (Fig. 6), although the effects failed to reach statistical significance in several of the dorsal subregions and one of the ventral subregions (Fig. 6B,C). The effects of environmental light cycles were not as robust on GABAAγ2-IR, however, protein-IR levels were higher in DD in the central anterior region in the whole SCN and the dorsal SCN (Fig. 6D) as well as in the central anterior (Fig. 6E,F) and posterior ventral SCN (Fig. 6F).
Table 5.
Protein | SCN region | t value | p value |
---|---|---|---|
δ | Whole SCN | (25) = −2.314 | *0.029 |
Rostral | (25) = −2.137 | *0.043 | |
Central anterior | (25) = −1.810 | 0.082 | |
Central posterior | (25) = −2.165 | *0.040 | |
Caudal | (25) = −2.636 | *0.014 | |
γ2 | Whole SCN | (21) = −1.544 | 0.142 |
Rostral | (24) = −0.806 | 0.428 | |
Central anterior | (24) = −2.761 | *0.011 | |
Central posterior | (23) = −1.582 | 0.127 | |
Caudal | (22) = −0.690 | 0.497 | |
δ | Dorsal whole SCN | (25) = −2.117 | *0.044 |
Dorsal rostral | (25) = −1.996 | 0.057 | |
Dorsal central anterior | (25) = −1.606 | 0.121 | |
Dorsal central posterior | (25) = −1.981 | 0.059 | |
Dorsal caudal | (25) = −2.356 | *0.027 | |
γ2 | Dorsal whole SCN | (21) = −1.203 | 0.242 |
Dorsal rostral | (24) = −0.672 | 0.508 | |
Dorsal central anterior | (24) = −2.799 | *0.010 | |
Dorsal central posterior | (23) = −1.160 | 0.258 | |
Dorsal caudal | (22) = −0.239 | 0.813 | |
δ | Ventral whole SCN | (25) = −2.615 | *0.015 |
Ventral rostral | (25) = −2.277 | *0.032 | |
Ventral central anterior | (25) = −2.036 | 0.052 | |
Ventral central posterior | (25) = −2.371 | *0.026 | |
Ventral caudal | (25) = −3.176 | *0.004 | |
γ2 | Ventral whole SCN | (21) = −2.178 | *0.041 |
Ventral rostral | (24) = −1.022 | 0.317 | |
Ventral central anterior | (24) = −2.283 | *0.032 | |
Ventral central posterior | (23) = −2.146 | *0.043 | |
Ventral caudal | (22) = −1.745 | 0.095 |
p < 0.05.
As discussed above the dorsal and ventral SCN have been shown to have different roles in entrainment (reviewed in Moore et al., 2002; Lee et al., 2003; Yan et al., 2007; Albers et al., 2017), thus we then analyzed our data to identify differences in GABAAR-IR between the dorsal and ventral SCN using an independent samples t test. The results of this analysis are found in Figure 7 and Table 6. We found no differences in GABAAδ protein-IR levels between the dorsal and ventral SCN at any time point in LD or DD (Fig. 7A–F). Compared with the dorsal region, the ventral SCN had higher levels of GABAAγ2 protein-IR late in the active phase (Fig. 7I,L). This effect was driven by higher protein-IR in the ventral central anterior region during the night in LD (ZT19; Fig. 7I) and by higher protein-IR in the ventral central posterior region during the subjective night in DD (CT19; Fig. 7L).
Table 6.
Protein | Time point | SCN region | t value | p value |
---|---|---|---|---|
δ | ZT6 | Whole SCN | (6) = −0.066 | 0.095 |
Rostral | (6) = −0.152 | 0.884 | ||
Central anterior | (6) = −0.139 | 0.896 | ||
Central posterior | (6) = −0.381 | 0.716 | ||
Caudal | (6) = 0.692 | 0.515 | ||
δ | ZT13 | Whole SCN | (6) = −0.398 | 0.704 |
Rostral | (6) = −0.489 | 0.642 | ||
Central anterior | (6) = −0.743 | 0.486 | ||
Central posterior | (6) = −0.197 | 0.850 | ||
Caudal | (6) = −0.111 | 0.915 | ||
δ | ZT19 | Whole SCN | (6) = −0.443 | 0.673 |
Rostral | (6) = −0.370 | 0.724 | ||
Central anterior | (6) = −0.506 | 0.631 | ||
Central posterior | (6) = −0.656 | 0.536 | ||
Caudal | (6) = −0.172 | 0.869 | ||
δ | CT6 | Whole SCN | (8) = −0.758 | 0.470 |
Rostral | (8) = −0.948 | 0.371 | ||
Central anterior | (8) = −0.660 | 0.528 | ||
Central posterior | (8) = −0.930 | 0.380 | ||
Caudal | (8) = −0.270 | 0.794 | ||
δ | CT13 | Whole SCN | (8) = −0.210 | 0.839 |
Rostral | (8) = −0.205 | 0.843 | ||
Central anterior | (8) = −0.363 | 0.726 | ||
Central posterior | (8) = −0.206 | 0.842 | ||
Caudal | (8) = −0.082 | 0.937 | ||
δ | CT19 | Whole SCN | (6) = −0.642 | 0.545 |
Rostral | (6) = −0.642 | 0.544 | ||
Central anterior | (6) = −0.875 | 0.415 | ||
Central posterior | (6) = −0.712 | 0.503 | ||
Caudal | (6) = −0.236 | 0.821 | ||
γ2 | ZT6 | Whole SCN | (6) = 0.162 | 0.877 |
Rostral | (6) = 0.347 | 0.741 | ||
Central anterior | (6) = 0.125 | 0.905 | ||
Central posterior | (6) = −0.145 | 0.889 | ||
Caudal | (6) = 0.197 | 0.850 | ||
γ2 | ZT13 | Whole SCN | (6) = 0.127 | 0.903 |
Rostral | (6) = 0.623 | 0.556 | ||
Central anterior | (6) = −1.115 | 0.308 | ||
Central posterior | (6) = −0.368 | 0.726 | ||
Caudal | (6) = 0.910 | 0.413 | ||
γ2 | ZT19 | Whole SCN | (4) = −1.076 | 0.343 |
Rostral | (6) = 0.034 | 0.974 | ||
Central anterior | (6) = −4.497 | *0.004 | ||
Central posterior | (6) = −1.240 | 0.261 | ||
Caudal | (4) = 0.106 | 0.156 | ||
γ2 | CT6 | Whole SCN | (6) = −0.931 | 0.388 |
Rostral | (8) = 0.041 | 0.969 | ||
Central anterior | (8) = −1.151 | 0.283 | ||
Central posterior | (6) = −1.796 | 0.123 | ||
Caudal | (8) = 0.018 | 0.986 | ||
γ2 | CT13 | Whole SCN | (6) = −0.217 | 0.836 |
Rostral | (8) = 0.347 | 0.738 | ||
Central anterior | (8) = −0.519 | 0.618 | ||
Central posterior | (8) = −1.708 | 0.127 | ||
Caudal | (6) = 0.085 | 0.935 | ||
γ2 | CT19 | Whole SCN | (6) = −2.620 | *0.040 |
Rostral | (6) = −0.207 | 0.843 | ||
Central anterior | (6) = −1.170 | 0.286 | ||
Central posterior | (6) = −3.037 | *0.023 | ||
Caudal | (6) = −2.514 | *0.046 |
p < 0.05.
Discussion
The different temporal patterns in the expression of δ and γ2 subunit mRNA and protein-IR observed across all subregions of the SCN suggests that GABAA-TONIC extrasynaptic receptors and GABAA-PHASIC synaptic receptors are differentially regulated within the SCN. Interestingly, while δ protein-IR levels did not significantly change across the circadian cycle, γ2 protein-IR displayed significant rhythmicity in the SCN of hamsters housed in LD and DD. Comparison of the relative changes in γ2 protein-IR in hamsters housed in LD and DD suggests that this protein may be regulated by the circadian pacemaker as well as by environmental light. In hamsters housed in DD, the relative amounts of γ2 protein-IR varied significantly over the circadian cycle with peak levels occurring during the subjective day (Fig. 4E). In hamsters housed in LD, the amounts of γ2 protein-IR also varied significantly, however, the lowest levels of γ2 protein-IR were observed during light phase (Fig. 4B) suggesting that environmental light inhibits γ2 protein levels. The possibility that δ protein levels are also inhibited by light cannot be excluded because the lower levels of this protein-IR seen during the light phase in LD approached but did not reach statistical significance (Fig. 4A). Additionally, hamsters housed in LD, compared with those housed in DD, had reduced protein-IR for both subunits, and this effect was strongest in the ventral SCN (Fig. 6). Taken together, these data suggest that when analyzed across the entire SCN GABAARs containing the δ subunit (i.e., extrasynaptic GABAA-TONIC receptors) remain relatively constant across time whereas GABAARs containing the γ2 subunit (i.e., synaptic GABAA-PHASIC receptors) are regulated by the circadian pacemaker, and both receptor subtypes may be influenced by environmental lighting conditions. Of course, the presence of GABAAR subunits alone does not indicate the presence of functional receptors (Olsen and Sieghart, 2008), so direct measures of tonic and phasic currents within neurons of the SCN across the circadian cycle will be necessary to further support this possibility.
Despite the significant temporal variations in γ2 protein-IR in the SCN of hamsters housed in DD and LD the ratio of the mean protein-IR levels of δ-to-γ2 did not change significantly when analyzed across all subdivisions of the nucleus. In contrast, however, the ratio of δ-to-γ2 protein-IR was found to change significantly across the circadian cycle in a region-specific manner. Specifically, the ratio of δ-to-γ2 protein-IR was significantly greater during the night than during the day but only in the subregion of the SCN that corresponds to the retinorecipient area of the nucleus (Fig. 5). These data suggest that within the discrete region of the SCN that is innervated by direct projections from the retina, the δ subunit containing extrasynaptic GABAA-TONIC receptors may play a larger role in mediating the response to GABA than the γ2 containing synaptic GABAA-PHASIC receptors during the night, while the opposite is true during the day. If GABAARs in the retinorecipient region of the SCN mediate the ability of GABA to alter circadian phase, then GABA agonists that act selectively on extrasynaptic GABAA-TONIC receptors would be predicted to be more efficacious in modulating phase shifts during the night while agonists that act selectively on synaptic GABAA-PHASIC receptors would be predicted to be more effective during the day. The data from experiment 1, along with previous work (Ehlen and Paul, 2009; McElroy et al., 2009), support this hypothesis. Injection of THIP, an extrasynaptic δ superagonist, inhibits the phase shifting effects of light at night but has no effect on circadian phase during the day, and diazepam, a benzodiazepine that acts on γ2 subunit containing GABAARs, phase shifts circadian rhythms during the day but does not influence circadian phase at night. Further, muscimol, which activates both extrasynaptic and synaptic GABAARs, influences circadian phase during both the day and night. These studies, however, should be interpreted with caution because the pharmacological actions of these drugs can be complicated (for a review, see Albers, et al., 2017), and there may be differences in processes downstream from GABAA signaling in the SCN which also influence the behavioral responses to GABAAR activation across the circadian cycle. Nevertheless, the significant increase in the ratio of δ-to-γ2 receptor protein-IR within the retinorecipient region of the SCN during the subjective night could indicate a shift in the balance of GABA’s effects from synaptic phasic modulation during the subjective day to extrasynaptic tonic modulation during the subjective night.
Other recent data also suggest that rhythms in the balance of tonic versus phasic GABAA-induced conductance may be important in determining the phase of the circadian pacemaker. It has recently been demonstrated that the sustained activation of GABAARs in the SCN (>4 h) is both necessary and sufficient for the induction of phase delays by light (Hummer et al., 2015). Interestingly, recent SCN modeling studies predict that sustained tonic GABA signaling, but not a sustained phasic GABA signaling, can phase shift the molecular pacemaker (DeWoskin et al., 2015). These data combined with the present findings that the ratio of tonic:phasic GABAARs may be highest during the subjective night within the retinorecipient subregion of the nucleus suggest the hypothesis that the sustained effects of GABA on phase resetting at night may be mediated by extrasynaptic GABAA-TONIC receptors. Thus, a sustained tonic GABA signal may necessarily need to be transduced through a nondesensitizing receptor, such as the extrasynaptic GABAA-TONIC receptor. Additional experiments will be necessary to determine which GABAAR subtype mediates the sustained effects of GABA on photic phase shifts, or whether both tonic and phasic receptors play a role in this intriguing process.
Data on GABAAR mRNA expression in the SCN are sparse in the literature. Using Northern blottings in extracts of the SCN from mice, transcripts were found for α1,2,3,4,5, β1,2,3, and γ1,2 subunits, however, transcripts for the δ and ρ subunits were not detected (O'Hara et al., 1995). Using microarray technology, transcripts for all 19 currently identified GABAAR subunits were found in the SCN of mice (Mouse 1.OST SCN 2014; Pizarro et al., 2013). It is interesting to note that within this same database in another dataset (mouse wild-type SCN, GNF Microarray), there was a diurnal rhythm in γ2 mRNA expression in the SCN of wild-type mice, with peak expression at night and nadir during the day. Interestingly, this expression pattern was antiphase in clock mutants with γ2 mRNA peak expression occurring during the day (Pizarro et al., 2013), suggesting that transcription of γ2 may be under control of one of the genes comprising the molecular circadian pacemaker (i.e., clock).
Studies on GABAA subunit protein expression in the SCN are also quite limited. Gao and colleagues investigated the protein expression of six different GABAAR subunits in the SCN of rats and found that IR was robust for α2, α3, α5, and γ2, but no staining was detected for α1 and β2/3 (Gao et al., 1995). However, this neuroanatomical study did not indicate the time of day the tissues were collected. Given that GABAAR subunit protein can vary considerably across the circadian cycle (Fig. 3; Naum et al., 2001), it is possible that the lack of IR reported for α1 and β2/3 was an artifact of time of day the tissues were collected. Indeed, both α1 and β2/3 mRNA expression has been reported in the SCN (O'Hara et al., 1995; Pizarro et al., 2013), as well as β3 protein (Naum et al., 2001; Belenky et al., 2003). To our knowledge, only one previous study has directly investigated temporal patterns of GABAAR protein expression in the SCN. Of the four subunits examined (α2, α5, β1, β3), only β1 was found to vary across the circadian cycle, with more protein at night (ZT16 and CT16) than during the day (ZT4 and CT4; Naum et al., 2001). Given that tissues were collected after only 2 d in DD, it is not clear whether this is a true circadian rhythm or a damped rhythm following exposure to the 14:10 LD cycle. As noted earlier, the presence of GABAA subunits does not necessarily demonstrate the existence of functional GABAARs containing those subunits (reviewed in Olsen and Sieghart, 2008). A pharmacological study of Zn2+-mediated GABAAR inhibition found greater inhibition of GABA-induced current during the day than at night in the SCN of rats housed in standard LD conditions (Kretschmannova et al., 2003). Given that GABAARs with a γ subunit are insensitive to Zn2+ inhibition, the authors concluded that the proportion of γ subunit containing receptors in the SCN was higher at night than during the day, which is consistent with our current findings in the SCN of hamsters housed in LD (Figs. 4, 5).
Our current findings that protein-IR patterns for GABAARs in the SCN are different from the expression patterns of their genes (Figs. 2, 4) is a phenomenon that has also been reported in other studies (described below) on transcript-protein expression relationships in the SCN. Peroxisome proliferator-activated receptor β/δ mRNA and protein display rhythmicity in the SCN of animals housed in LD cycles, but in DD, mRNA expression remains rhythmic whereas protein expression does not (Challet et al., 2013). Further evidence that transcript and protein rhythms can be uncoupled comes from a recent SCN proteome study that analyzed 2112 proteins. This study concluded that “transcript levels are a poor predictor of protein abundance” based on the finding that among 421 transcripts which were expressed in a 24 h pattern, only nine of the proteins corresponding to those transcripts were rhythmically expressed (Chiang et al., 2014). Taken together, these findings suggest that the circadian protein rhythms of GABAARs subunits and their ratios in the SCN are more likely to be regulated by posttranscriptional factors than by transcriptional rhythms.
How might rhythms in protein expression and relative ratios of proteins develop independent of rhythms (or lack thereof) in transcripts? One possibility is that homeostatic reciprocal regulation between GABAAδ and GABAAγ2 proteins may affect their expression in a seesaw manner (Korpi et al., 2002; Wu et al., 2013), resulting in the different effects of tonic and phasic GABAA agonists across the circadian cycle in the SCN. This mechanistically simple hypothesis does not appear to be supported by our data across the whole SCN, as changes in GABAAγ2 protein-IR are not accompanied by significant and reciprocal changes in GABAAδ protein-IR (Fig. 4). Indeed, lighting conditions (LD vs DD) appear to have a greater influence on the expression of GABAARs than homeostatic competition driven by their relative abundance (Figs. 4–6). The interaction of light and circadian phase on GABAAR ratio in the retinorecipient SCN (Fig. 5G–I) does suggest that protein expression in this area may be differentially regulated than in other SCN regions. Thus, it may be possible that homeostatic reciprocal regulation between GABAAδ and GABAAγ2 protein may indeed occur in the retinorecipient SCN.
In conclusion, circadian rhythms in the ratio of δ-to-γ2 GABAAR-IR in the retinorecipient SCN may mediate the phase-dependent effects of GABA on the circadian pacemaker. Within the circadian pacemaker, patterns of GABAAR transcript expression do not predict patterns of protein expression, and light appears to have a greater influence on GABAAR protein expression than does circadian transcriptional regulation. Although the effects of environmental light on GABAAR protein-IR are apparent across the entire SCN, the retinorecipient area is differentially affected. These findings provide insight into the complex effects of GABA in the SCN across the circadian cycle and highlight the need for future studies to identify the exact subunit composition, anatomic distribution, temporal patterns of expression, and regulatory factors influencing the expression and function of GABAARs in the circadian pacemaker.
Acknowledgments
Acknowledgements: We thank Dr. Kim Huhman, Dr. Amy Ross, Dr. Brittany Thompson, Dr. Adriano Senatore, Tony Larkin, Madeline Long, and Alisa Norvelle for assistance with these experiments. We also thank Ancilla Titus-Scotland and Robert Bynes for animal husbandry.
Synthesis
Reviewing Editor: Rae Silver, Columbia University
Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: Charles Allen, Rebecca Prosser
As previously noted, the research indicates that two GABA(A) receptor subunits are expressed throughout the suprachiasmatic nucleus. The data also suggest that there is a small rhythm in the expression of the subunits that might contribute to different roles for synaptic and extrasynaptic GABA(A) receptors in the SCN. The authors have been responsive to prior reviews, and at this point some small revisions are suggested. These will be reviewed by the editor (only).
The manuscript tends to overstate the significance of the data, given that the rhythms shown, while statistically significant, are small relative to the total protein/mRNA levels. This can be clarified by changing the visual abstract to reflect a less dramatic day/night difference in the abundance of the two subunits. The significance statement and abstract discuss these differences as a change in balance, which is well put and more accurate. Also, the discussion might state directly that combining the two nighttime data sets and comparing them to the daytime reflects a functional grouping and is reasonable, and that it was necessary because of the subtle rhythms being measured. That said, given that the effects are subtle, this may suggest that the role of the two populations of receptors in the behavioral responses is more related to their downstream signaling (among other possible mechanisms) than to changes in their expression pattern?
Please address these comments; the changes will be reviewed by the editor only.
References
- Albers HE, Ottenweller JE, Liou SY, Lumpkin MD, Anderson ER (1990) Neuropeptide Y in the hypothalamus: effect on corticosterone and single-unit activity. Am J Physiol 258:R376–R382. [DOI] [PubMed] [Google Scholar]
- Albers HE, Walton JC, Gamble KL, McNeill JKI, Hummer DL (2017) The dynamics of GABA signaling: revelations from the circadian pacemaker in the suprachiasmatic nucleus. Front Neuroendocrinol 44:35–82. 10.1016/j.yfrne.2016.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Araujo F, Ruano D, Vitorica J (1998) Absence of association between delta and gamma2 subunits in native GABA(A) receptors from rat brain. Eur J Pharmacol 347:347–353. [DOI] [PubMed] [Google Scholar]
- Belenky MA, Sagiv N, Fritschy JM, Yarom Y (2003) Presynaptic and postsynaptic GABAA receptors in rat suprachiasmatic nucleus. Neuroscience 118:909–923. [DOI] [PubMed] [Google Scholar]
- Biello SM (2009) Circadian clock resetting in the mouse changes with age. Age (Dordr) 31:293–303. 10.1007/s11357-009-9102-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brunig I, Suter A, Knuesel I, Luscher B, Fritschy JM (2002) GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin. J Neurosci 22:4805–4813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caldwell HK, Albers HE (2003) Short-photoperiod exposure reduces vasopressin (V1a) receptor binding but not arginine-vasopressin-induced flank marking in male Syrian hamsters. J Neuroendocrinol 15:971–977. 10.1046/j.1365-2826.2003.01086.x [DOI] [PubMed] [Google Scholar]
- Castel M, Morris JF (2000) Morphological heterogeneity of the GABAergic network in the suprachiasmatic nucleus, the brain's circadian pacemaker. J Anat 196:1–13. 10.1046/j.1469-7580.2000.19610001.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Challet E, Denis I, Rochet V, Aïoun J, Gourmelen S, Lacroix H, Goustard-Langelier B, Papillon C, Alessandri JM, Lavialle M (2013) The role of PPARβ/δ in the regulation of glutamatergic signaling in the hamster suprachiasmatic nucleus. Cell Mol Life Sci 70:2003–2014. 10.1007/s00018-012-1241-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chiang CK, Mehta N, Patel A, Zhang P, Ning Z, Mayne J, Sun WY, Cheng HY, Figeys D (2014) The proteomic landscape of the suprachiasmatic nucleus clock reveals large-scale coordination of key biological processes. PLoS Genet 10:e1004695. 10.1371/journal.pgen.1004695 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Blüthmann H, Möhler H, Rudolph U (2002) Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci USA 99:8980–8985. 10.1073/pnas.142288699 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Danglot L, Triller A, Bessis A (2003) Association of gephyrin with synaptic and extrasynaptic GABAA receptors varies during development in cultured hippocampal neurons. Mol Cell Neurosci 23:264–278. [DOI] [PubMed] [Google Scholar]
- DeWoskin D, Myung J, Belle MD, Piggins HD, Takumi T, Forger DB (2015) Distinct roles for GABA across multiple timescales in mammalian circadian timekeeping. Proc Natl Acad Sci USA 112:E3911–E3919. 10.1073/pnas.1420753112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drasbek KR, Jensen K (2006) THIP, a hypnotic and antinociceptive drug, enhances an extrasynaptic GABAA receptor-mediated conductance in mouse neocortex. Cereb Cortex 16:1134–1141. 10.1093/cercor/bhj055 [DOI] [PubMed] [Google Scholar]
- Ehlen JC, Paul KN (2009) Regulation of light's action in the mammalian circadian clock: role of the extrasynaptic GABAA receptor. Am J Physiol Regul Integr Comp Physiol 296:R1606–R1612. 10.1152/ajpregu.90878.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ehlen JC, Novak CM, Karom MC, Gamble KL, Paul KN, Albers HE (2006) GABAA receptor activation suppresses Period 1 mRNA and Period 2 mRNA in the suprachiasmatic nucleus during the mid-subjective day. Eur J Neurosci 23:3328–3336. 10.1111/j.1460-9568.2006.04857.x [DOI] [PubMed] [Google Scholar]
- Essrich C, Lorez M, Benson JA, Fritschy JM, Lüscher B (1998) Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat Neurosci 1:563–571. 10.1038/2798 [DOI] [PubMed] [Google Scholar]
- Evans JA (2016) Collective timekeeping among cells of the master circadian clock. J Endocrinol 230:R27–R49. 10.1530/JOE-16-0054 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans JA, Gorman MR (2016) In synch but not in step: circadian clock circuits regulating plasticity in daily rhythms. Neuroscience 320:259–280. 10.1016/j.neuroscience.2016.01.072 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farrant M, Nusser Z (2005) Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6:215–229. 10.1038/nrn1625 [DOI] [PubMed] [Google Scholar]
- Fritschy JM, Panzanelli P (2014) GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system. Eur J Neurosci 39:1845–1865. 10.1111/ejn.12534 [DOI] [PubMed] [Google Scholar]
- Gao B, Fritschy JM, Moore RY (1995) GABAA-receptor subunit composition in the circadian timing system. Brain Res 700:142–156. [DOI] [PubMed] [Google Scholar]
- Gillespie CF, Huhman KL, Babagbemi TO, Albers HE (1996) Bicuculline increases and muscimol reduces the phase-delaying effects of light and VIP/PHI/GRP in the suprachiasmatic region. J Biol Rhythms 11:137–144. 10.1177/074873049601100206 [DOI] [PubMed] [Google Scholar]
- Gillespie CF, Mintz EM, Marvel CL, Huhman KL, Albers HE (1997) GABA(A) and GABA(B) agonists and antagonists alter the phase-shifting effects of light when microinjected into the suprachiasmatic region. Brain Res 759:181–189. [DOI] [PubMed] [Google Scholar]
- Gillespie CF, Van Der Beek EM, Mintz EM, Mickley NC, Jasnow AM, Huhman KL, Albers HE (1999) GABAergic regulation of light-induced c-Fos immunoreactivity within the suprachiasmatic nucleus. J Comp Neur 411:683–692. [PubMed] [Google Scholar]
- Hamada T, Antle MC, Silver R (2004) Temporal and spatial expression patterns of canonical clock genes and clock-controlled genes in the suprachiasmatic nucleus. Eur J Neurosci 19:1741–1748. 10.1111/j.1460-9568.2004.03275.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hansen SL, Ebert B, Fjalland B, Kristiansen U (2001) Effects of GABA(A) receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions. Br J Pharmacol 133:539–549. 10.1038/sj.bjp.0704121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huhman KL, Babagbemi TO, Albers HE (1995) Bicuculline blocks neuropeptide Y-induced phase advances when microinjected in the suprachiasmatic nucleus of Syrian hamsters. Brain Res 675:333–336. [DOI] [PubMed] [Google Scholar]
- Hummer DL, Ehlen JC, Larkin TE 2nd, McNeill JK 4th, Pamplin JR 2nd, Walker CA, Walker PV, 2nd, Dhanraj DR, Albers HE (2015) Sustained activation of GABAA receptors in the suprachiasmatic nucleus mediates light-induced phase delays of the circadian clock: a novel function of ionotropic receptors. Eur J Neurosci 42:1830–1838. 10.1111/ejn.12918 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Institute for Laboratory Animal Research (U.S.) (2011) Guide for the care and use of laboratory animals, Ed 8. Washington, DC: National Academies Press. [Google Scholar]
- Korpi ER, Mihalek RM, Sinkkonen ST, Hauer B, Hevers W, Homanics GE, Sieghart W, Lüddens H (2002) Altered receptor subtypes in the forebrain of GABA(A) receptor delta subunit-deficient mice: recruitment of gamma 2 subunits. Neuroscience 109:733–743. [DOI] [PubMed] [Google Scholar]
- Kretschmannova K, Svobodova I, Zemkova H (2003) Day-night variations in zinc sensitivity of GABAA receptor-channels in rat suprachiasmatic nucleus. Brain Res Mol Brain Res 120:46–51. [DOI] [PubMed] [Google Scholar]
- Lee HS, Billings HJ, Lehman MN (2003) The suprachiasmatic nucleus: a clock of multiple components. J Biol Rhythms 18:435–449. 10.1177/0748730403259106 [DOI] [PubMed] [Google Scholar]
- LeSauter J, Kriegsfeld LJ, Hon J, Silver R (2002) Calbindin-D(28K) cells selectively contact intra-SCN neurons. Neuroscience 111:575–585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lydic R, Albers HE, Tepper B, Moore-Ede MC (1982) Three-dimensional structure of the mammalian suprachiasmatic nuclei: a comparative study of five species. J Comp Neur 204:225–237. 10.1002/cne.902040303 [DOI] [PubMed] [Google Scholar]
- McElroy B, Zakaria A, Glass JD, Prosser RA (2009) Ethanol modulates mammalian circadian clock phase resetting through extrasynaptic GABA receptor activation. Neuroscience 164:842–848. 10.1016/j.neuroscience.2009.08.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mintz EM, Jasnow AM, Gillespie CF, Huhman KL, Albers HE (2002) GABA interacts with photic signaling in the suprachiasmatic nucleus to regulate circadian phase shifts. Neuroscience 109:773–778. [DOI] [PubMed] [Google Scholar]
- Moore RY, Speh JC (1993) GABA is the principal neurotransmitter of the circadian system. Neurosci Lett 150:112–116. [DOI] [PubMed] [Google Scholar]
- Moore RY, Speh JC, Leak RK (2002) Suprachiasmatic nucleus organization. Cell Tissue Res 309:89–98. 10.1007/s00441-002-0575-2 [DOI] [PubMed] [Google Scholar]
- Morin LP (2007) SCN organization reconsidered. J Biol Rhythms 22:3–13. 10.1177/0748730406296749 [DOI] [PubMed] [Google Scholar]
- Morin LP, Allen CN (2006) The circadian visual system, 2005. Brain Res Rev 51:1–60. 10.1016/j.brainresrev.2005.08.003 [DOI] [PubMed] [Google Scholar]
- Morin LP, Wood RI (2001) A stereotaxic atlas of the golden hamster brain. San Diego, CA: Academic Press. [Google Scholar]
- Mrosovsky N (1996) Locomotor activity and non-photic influences on circadian clocks. Biol Rev Camb Philos Soc 71:343–372. [DOI] [PubMed] [Google Scholar]
- Mrosovsky N, Salmon PA, Menaker M, Ralph MR (1992) Nonphotic phase shifting in hamster clock mutants. J Biol Rhythms 7:41–49. 10.1177/074873049200700104 [DOI] [PubMed] [Google Scholar]
- Naum OG, Fernanda Rubio M, Golombek DA (2001) Rhythmic variation in gamma-aminobutyric acid(A)-receptor subunit composition in the circadian system and median eminence of Syrian hamsters. Neurosci Lett 310:178–182. 10.1016/S0304-3940(01)02129-2 [DOI] [PubMed] [Google Scholar]
- Novak CM, Albers HE (2004) Circadian phase alteration by GABA and light differs in diurnal and nocturnal rodents during the day. Behav Neurosci 118:498–504. 10.1037/0735-7044.118.3.498 [DOI] [PubMed] [Google Scholar]
- O'Hara BF, Andretic R, Heller HC, Carter DB, Kilduff TS (1995) GABAA, GABAC, and NMDA receptor subunit expression in the suprachiasmatic nucleus and other brain regions. Brain Res Mol Brain Res 28:239–250. [DOI] [PubMed] [Google Scholar]
- Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60:243–260. 10.1124/pr.108.00505 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olsen RW, Sieghart W (2009) GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56:141–148. 10.1016/j.neuropharm.2008.07.045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paul KN, Fukuhara C, Karom M, Tosini G, Albers HE (2005) AMPA/kainate receptor antagonist DNQX blocks the acute increase of Per2 mRNA levels in most but not all areas of the SCN. Brain Res Mol Brain Res 139:129–136. 10.1016/j.molbrainres.2005.05.017 [DOI] [PubMed] [Google Scholar]
- Peng Z, Huang CS, Stell BM, Mody I, Houser CR (2004) Altered expression of the delta subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. J Neurosci 24:8629–8639. 10.1523/JNEUROSCI.2877-04.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pittendrigh CS, Daan S (1976) A functional analysis of circadian pacemakers in nocturnal rodents I. The stability and lability of spontaneous frequency. J Comp Physiol 106:223–252. 10.1007/BF01417856 [DOI] [Google Scholar]
- Pizarro A, Hayer K, Lahens NF, Hogenesch JB (2013) CircaDB: a database of mammalian circadian gene expression profiles. Nucleic Acids Res 41:D1009–D1013. 10.1093/nar/gks1161 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sigel E, Steinmann ME (2012) Structure, function, and modulation of GABA(A) receptors. J Biol Chem 287:40224–40231. 10.1074/jbc.R112.386664 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith RD, Inouye S, Turek FW (1989) Central administration of muscimol phase-shifts the mammalian circadian clock. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 164:805–814. [DOI] [PubMed] [Google Scholar]
- Stell BM, Mody I (2002) Receptors with different affinities mediate phasic and tonic GABA(A) conductances in hippocampal neurons. J Neurosci 22:RC223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stephan FK, Zucker I (1972) Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 69:1583–1586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Terai K, Tooyama I, Kimura H (1998) Immunohistochemical localization of GABAA receptors in comparison with GABA-immunoreactive structures in the nucleus tractus solitarii of the rat. Neuroscience 82:843–852. [DOI] [PubMed] [Google Scholar]
- van den Pol AN (1986) Gamma-aminobutyrate, gastrin releasing peptide, serotonin, somatostatin, and vasopressin: ultrastructural immunocytochemical localization in presynaptic axons in the suprachiasmatic nucleus. Neuroscience 17:643–659. [DOI] [PubMed] [Google Scholar]
- Wu X, Huang L, Wu Z, Zhang C, Jiang D, Bai Y, Wang Y, Chen G (2013) Homeostatic competition between phasic and tonic inhibition. J Biol Chem 288:25053–25065. 10.1074/jbc.M113.491464 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yan L, Karatsoreos I, Lesauter J, Welsh DK, Kay S, Foley D, Silver R (2007) Exploring spatiotemporal organization of SCN circuits. Cold Spring Harb Symp Quant Biol 72:527–541. 10.1101/sqb.2007.72.037 [DOI] [PMC free article] [PubMed] [Google Scholar]